Literature DB >> 7125846

A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands.

E S Gershon, J Hamovit, J J Guroff, E Dibble, J F Leckman, W Sceery, S D Targum, J I Nurnberger, L R Goldin, W E Bunney.   

Abstract

In a family study of 1,254 adult relatives of patients and controls, lifetime prevalences of major affective disorder (including schizoaffective) were 37%, 24%, 25%, 20% and 7% in relatives of probands with schizoaffective, bipolar I, bipolar II, and unipolar disease, and normal controls. These data were compatible with the different affective disorders representing thresholds on a continuum of underlying multifactorial vulnerability. In this model, schizoaffective illness represents greatest vulnerability, followed by bipolar I and bipolar II, then unipolar illnesses. Alcoholism, drug abuse, and sociopathy were not more frequent in relatives of patients v relatives of controls. Sex-related transmission of morbid risk was not present. Morbid risk was 74% to offspring of two III parents, and 27% to offspring of one III parent. Nationality and age at time of interview seem to be nongenetic factors that affect frequency of diagnosis.

Entities:  

Mesh:

Year:  1982        PMID: 7125846     DOI: 10.1001/archpsyc.1982.04290100031006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  126 in total

Review 1.  The bipolar spectrum--the shaping of a new paradigm in psychiatry.

Authors:  Hagop S Akiskal
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 2.  Review of bipolar molecular linkage and association studies.

Authors:  Wade Berrettini
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

3.  The power and statistical behaviour of allele-sharing statistics when applied to models with two disease loci.

Authors:  Yin Y Shugart; Bing-Jian Feng; Andrew Collins
Journal:  J Genet       Date:  2002-12       Impact factor: 1.166

Review 4.  Bipolar disorder and schizophrenia: convergent molecular data.

Authors:  Wade Berrettini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

5.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

6.  Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.

Authors:  David T Dao; Pamela Belmonte Mahon; Xiang Cai; Colleen E Kovacsics; Robert A Blackwell; Michal Arad; Jianxin Shi; Peter P Zandi; Patricio O'Donnell; James A Knowles; Myrna M Weissman; William Coryell; William A Scheftner; William B Lawson; Douglas F Levinson; Scott M Thompson; James B Potash; Todd D Gould
Journal:  Biol Psychiatry       Date:  2010-08-17       Impact factor: 13.382

7.  The longitudinal course of comorbid oppositional defiant disorder in girls with attention-deficit/hyperactivity disorder: findings from a controlled 5-year prospective longitudinal follow-up study.

Authors:  Joseph Biederman; Carter R Petty; Michael C Monuteaux; Eric Mick; Tiffany Parcell; Diana Westerberg; Stephen V Faraone
Journal:  J Dev Behav Pediatr       Date:  2008-12       Impact factor: 2.225

Review 8.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Authors:  N Craddock; M C O'Donovan; M J Owen
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

9.  A pilot Swedish twin study of affective illness including hospital- and population-ascertained subsamples: results of model fitting.

Authors:  K S Kendler; N L Pedersen; M C Neale; A A Mathé
Journal:  Behav Genet       Date:  1995-05       Impact factor: 2.805

10.  Parsing the familiality of oppositional defiant disorder from that of conduct disorder: a familial risk analysis.

Authors:  Carter R Petty; Michael C Monuteaux; Eric Mick; Samantha Hughes; Jacqueline Small; Stephen V Faraone; Joseph Biederman
Journal:  J Psychiatr Res       Date:  2008-05-01       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.